Quality of life of treated opiate addicts in the methadone maintenance program and those treated with buprenorphine
Abstract
Background/Aim. Although the characteristics of the treatment are the most researched determinants of quality of life of opiate addicts, it is indisputable that there is a certain influence of the characteristics of addicts and addiction, too. The aim of this study was to determine which addicts characteristics, as well as the characteristics of the addiction and treatment have predicative influence on the quality of life of the opiate addicts treated in the methadone maintenance program and those treated with buprenorphine. Methods. The epidemiological cross-sectional study was carried out in 2013 at the Clinical Center Niš, on a total of 64 opiate addicts, both sexes, aged 18 and older (32 addicts in the methadone program, chosen by random selection, and 32 addicts treated with buprenorphine, matched by sex and age). Necessary data were collected in a “face to face” interview with the examinees, based on the autonomous kind of a questionnaire, together with the use of the standardized World Health Organization (WHO) instruments: for health status, for the level of severity of addiction and for the quality of life measuring) based on which the health index (EQ-5D), Addiction Severity Index (ASI) and the quality of life index (WHOQOL-BREF) were calculated. The data were described by the methods of descriptive statistics, while the differences between groups were analyzed by applying χ2 and t-test. Multiple regressions were used to determine the predictors. Results. The addicts in the methadone program showed much worse perception of quality of life than those treated in another way, although, according to the values of quality of life, they did not differ significantly. The most numerous predictors of the level of quality of life were health characteristics, characteristics of the socioeconomic position of the examinees, as well as different consequences of addiction. The influence of treatment was less noticeable. Participating in the methadone program had predicative influence on perception and the level of quality of life of the addicts in mental area and that of the environment. The influence of the characteristics of methadone treatment in physical and social area was insignificant.
Conclusion. Variations in the perception and level of the quality of life of opiate addicts in different areas cannot be explained using only one predictor. The number of determining variables is large, and its impact complex.
References
Baharom N, Hassan MR, Ali N, Shah SA. Improvement of qual-ity of life following 6 months of methadone maintenance therapy in Malaysia. Subst Abuse Treat Prev Policy 2012; 7: 32.
Feelemyer JP, Des Jarlais DC, Arasteh K, Phillips BW, Hagan H. Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an in-ternational systematic review. Drug Alcohol Depend 2014; 134: 251−8.
Maremmani I, Pani PP, Pacini M, Perugi G. Substance use and quality of life over 12 months among buprenorphine mainten-ance-treated and methadone maintenance-treated heroin-addicted patients. J Subst Abuse Treat 2007; 33(1): 91−8.
Xiao L, Wu Z, Luo W, Wei X. Quality of life of outpatients in methadone maintenance treatment clinics. Acquir Immune Defic Syndr 2010; 53 Suppl 1: S116−20.
Lashkaripour K, Bakhshani NM, Sadjadi SA. Quality of life in pa-tients on methadone maintenance treatment: A three-month assessment. J Pak Med Assoc 2012; 62(10): 1003−7.
Padaiga Z, Subata E, Vanagas G. Outpatient methadone main-tenance treatment program. Quality of life and health of opio-id-dependent persons in Lithuania. Medicina (Kaunas) 2007; 43(3): 235−41.
Dhawan A, Chopra A. Does buprenorphine maintenance im-prove the quality of life of opioid users. Indian J Med Res 2013; 137(1): 130−5.
Chou YC, Shih SF, Tsai WD, Li CS, Xu K, Lee TS. Improve-ment of quality of life in methadone treatment patients in northern Taiwan: A follow-up study. BMC Psychiatry 2013; 13: 190.
Huong AG, Ng CG, Amer SA. Quality of life assessment of opioid substance abusers on methadone maintenance therapy (MMT) in University Malaya Medical Centre. Asian J Psychiatr 2009; 10: 1–11.
Parmenter J, Mitchell C, Keen J, Oliver P, Rowse G, Neligan I, et al. Predicting biopsychosocial outcomes for heroin users in pri-mary care treatment: a prospective longitudinal cohort study. Br J Gen Pract 2013; 63(612): e499−505.
Pang L, Hao Y, Mi G, Wang C, Luo W, Rou K, et al. Effective-ness of first eight methadone maintenance treatment clinics in China. AIDS 2007; 21 Suppl 8: S103−7.
De Maeyer J, Vanderplasschen W, Camfield L, Vanheule S, Sabbe B, Broekaert E. A good quality of life under the influence of me-thadone: A qualitative study among opiate-dependent individ-uals. Int J Nurs Stud 2011; 48(10): 1244−57.
De Maeyer J, Vanderplasschen W, Lammertyn J, van Nieuwenhuizen C, Broekaert E. Exploratory study on domain-specific determi-nants of opiate-dependent individuals' quality of life. Eur Ad-dict Res 2011; 17(4): 198−210.
De Maeyer J, Vanderplasschen W, Broekaert E. Exploratory Study on Drug Users’ Perspectives on Quality of Life: More than Health-Related Quality of Life. Soc Indic Res 2009; 90(1): 107−26.
Marijanović M. The influence of the length of methadone main-tenance treatment on quality of life of opioid addicts. Racio-nalna terapija 2014; 6(1): doi: 10.5937/racter6-4300. (Serbian)
Shekarchizadeh H, Ekhtiari H, Khami MR, Virtanen JI. Patterns of pre-treatment drug abuse, drug treatment history and cha-racteristics of addicts in methadone maintenance treatment in Iran. Harm Reduct J 2012; 9: 18.
Rouhani S, Kheirkhah F, Salarieh I, Abedi S. Quality of life, its early change and retention in MMT program in Iran: Evidence for policymakers and service providers. Life Sci J 2012; 9(3): 2633−8.
Huissoud T, Rousson V, Dubois-Arber F. Methadone treatments in a Swiss region, 2001-2008: A registry-based analysis. BMC Psychiatry 2012; 1 2: 238.
De Maeyer J, Nieuwenhuizen C, Bongers IL, Broekaert E, Vander-plasschen W. Profiles of quality of life in opiate-dependent indi-viduals after starting methadone treatment: A latent class anal-ysis. Int J Drug Policy 2013; 24(4): 342−50.
Gossop M, Marsden J, Stewart D, Treacy S. Outcomes after me-thadone maintenance and methadone reduction treatments: Two-year follow-up results from the National Treatment Out-come Research Study. Drug Alcohol Depend 2001; 62(3): 255−64.
Tran BX, Ohinmaa A, Nguyen LT, Oosterhoff P, Vu PX, Vu TV, et al. Gender differences in quality of life outcomes of HIV/AIDS treatment in the latent feminization of HIV epi-demics in Vietnam. AIDS Care 2012; 24(10): 1187−96.
Tran BX, Ohinmaa A, Nguyen LT, Nguyen TA, Nguyen TH. De-terminants of health-related quality of life in adults living with HIV in Vietnam. AIDS Care 2011; 23(10): 1236−45.
Bawor M, Dennis BB, Anglin R, Steiner M, Thabane L, Samaan Z. Sex differences in outcomes of methadone maintenance treatment for opioid addiction: A systematic review protocol. Syst Rev 2014; 16: 3−45.
Millson P, Challacombe L, Villeneuve PJ, Strike CJ, Fischer B, Myers T, et al. Determinants of Health Related Quality of Life (HRQOL) of Opiate Users at Entry to Low Threshold Methadone Programs. J Subst Use 2006; 11(2): 137−49.
Tracy EM, Laudet AB, Min MO, Kim H, Brown S, Jun MK, et al. Prospective patterns and correlates of quality of life among women in substance abuse treatment. Drug Alcohol Depend 2012; 124(3): 242−9.
Zhao L, Holzemer WL, Johnson M, Tulsky JP, Rose CD. HIV in-fection as a predictor of methadone maintenance outcomes in Chinese injection drug users. AIDS Care 2012; 24(2): 195−203.
EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 199; 16(3): 199−208.
Szende A, Oppe M, Devlin N. EQ-5D value sets: Inventory, comparative review and user guide. Dordrecht: Springer; 2006.
McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9(3): 199−213.
World Health Organization. Quality of life (WHOQOL-BREF). Procedures Manual. Geneva: World Health Organization; 2004.